DISTINCTION OF ANTI-K562 AND ANTI-ALLOCYTOTOXICITY IN INVITRO-STIMULATED POPULATIONS OF HUMAN-LYMPHOCYTES

被引:41
作者
POROS, A
KLEIN, E
机构
关键词
D O I
10.1016/0008-8749(79)90245-4
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The properties of lymphocytes cultivated with K562 (MKC)-a cell line which lacks HLA antigens and is sensitive to natural cytotoxicity-was compared to conventional mixed lymphocyte cultures (MLC). The characteristics of the two cultures differed. In the MKC there were fewer E positive blasts and more FcR-positive cells, and a higher proportion of the T cells was nylon adherent. The cells of both cultures were cytotoxic against K562. Against the sensitizer alloblasts, MLC populations were regularly more active than lymphocytes derived from the same donor but cultivated with K562. As indicated by the relative cytotoxic efficiencies of MLC subsets, part of the the killer cells affecting K562 and alloblasts differed in the expression of E receptors. Acting similarly to natural killers in the fresh blood, anti-K562 effectors were more abundant in the subsets which did not sediment as SRBC rosettes. In contrast, the specific alloreactivity was more pronounced with the SRBC-rosetting cells. © 1979.
引用
收藏
页码:57 / 68
页数:12
相关论文
共 39 条
[1]   CHARACTERIZATION OF HUMAN LYMPHOCYTE SUBPOPULATIONS FOR CYTOTOXICITY AGAINST TUMOR-DERIVED MONOLAYER-CULTURES [J].
BAKACS, T ;
GERGELY, P ;
CORNAIN, S ;
KLEIN, E .
INTERNATIONAL JOURNAL OF CANCER, 1977, 19 (04) :441-449
[2]   CHARACTERIZATION OF CYTOTOXIC HUMAN LYMPHOCYTE SUBPOPULATIONS - ROLE OF FC-RECEPTOR-CARRYING CELLS [J].
BAKACS, T ;
GERGELY, P ;
KLEIN, E .
CELLULAR IMMUNOLOGY, 1977, 32 (02) :317-328
[3]  
BOLHUIS RLH, 1977, CANCER IMMUNOL IMMUN, V2, P245
[4]  
BONNARD GD, 1977, PROGR IMMUNOLOGY, V3, P547
[5]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[6]  
BUTTERWORTH AE, 1975, CELL IMMUNOL, V16, P44
[7]  
CALLEWAERT DM, 1978, J IMMUNOL, V121, P81
[8]  
de Vries J E, 1974, Int J Cancer, V14, P427, DOI 10.1002/ijc.2910140402
[9]  
DREW SI, 1977, BLOOD, V49, P715
[10]  
GALILI U, 1976, J IMMUNOL, V117, P730